escitalopram
- Product NDC
- 13668-135
- 11-digit product format
- 136680135
- Labeler code
- 13668
- Product ID
- 13668-135_aa1ecae7-8a57-434f-a72b-088335b1a42c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- escitalopram
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Torrent Pharmaceuticals Limited
- Application
- ANDA090939
- Marketing category
- ANDA
- Marketing start
- 2012-09-11
- Substance
- ESCITALOPRAM OXALATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- escitalopram
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ESCITALOPRAM OXALATE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 5U85DBW7LO |
| Rxcui | 349332, 351249, 351250 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 13668-135-01 | escitalopram | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | | 28 |
| 13668-135-05 | escitalopram | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | | 28 |
| 13668-135-10 | escitalopram | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | | 28 |
| 13668-135-30 | escitalopram | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 28 |
| 13668-135-40 | escitalopram | 4000 in 1 BOTTLE | TABLET, FILM COATED | 4000 | | 28 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ESCITALOPRAM OXALATE | ACTIVE INGREDIENT | 5U85DBW7LO | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| ESCITALOPRAM | ACTIVE MOIETY | 4O4S742ANY | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ESCITALOPRAM OXALATE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 7 | |
| ESCITALOPRAM OXALATE | ACTIVE INGREDIENT | 5U85DBW7LO | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ESCITALOPRAM | ACTIVE MOIETY | 4O4S742ANY | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | ESCITALOPRAM OXALATE TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 13668-135 | ESCITALOPRAM TABLET, FILM COATED [TORRENT PHARMACEUTICALS LIMITED] | 27 | Current NDC, Legacy NDC, 5 package rows | 20250125_068bb338-23f3-4278-958b-c34b40456024.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 13668-135-01 | 13668013501 | 100 TABLET, FILM COATED in 1 BOTTLE (13668-135-01) | | 2012-09-11 | 0000-00-00 | No | No | Current |
| 13668-135-05 | 13668013505 | 500 TABLET, FILM COATED in 1 BOTTLE (13668-135-05) | | 2012-09-11 | 0000-00-00 | No | No | Current |
| 13668-135-10 | 13668013510 | 1000 TABLET, FILM COATED in 1 BOTTLE (13668-135-10) | | 2012-09-11 | 0000-00-00 | No | No | Current |
| 13668-135-30 | 13668013530 | 30 TABLET, FILM COATED in 1 BOTTLE (13668-135-30) | | 2012-09-11 | 0000-00-00 | No | No | Current |
| 13668-135-40 | 13668013540 | 4000 TABLET, FILM COATED in 1 BOTTLE (13668-135-40) | | 2012-09-11 | 0000-00-00 | No | No | Current |
| 13668-135-74 | 13668013574 | 100 TABLET in 1 CARTON (13668-135-74) | 100 tablet | 2012-09-11 | 0000-00-00 | No | No | Current |